CIC
EWTX icon

Cornercap Investment Counsel’s Edgewise Therapeutics EWTX Stock Holding History

Cornercap Investment Counsel’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,023
Closed -$149K – 608
2023
Q3 		$149K Buy
26,023
+916
+4% +$6.23K 0.03% 514
2023
Q2 		$195K Sell
25,107
-6,797
-21% -$57.3K 0.03% 516
2023
Q1 		$213K Buy
+31,904
New +$296K 0.04% 496

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cornercap Investment Counsel's EWTX Position: Q4 2023 in Review

Cornercap Investment Counsel sold out of Edgewise Therapeutics (EWTX) in Q4 2023, closing a stake of 26,023 shares — an estimated $149K sold.

Cornercap Investment Counsel first reported a position in EWTX in Q1 2023 and held it in 3 quarters. The position peaked at $213K in Q1 2023. 116 funds tracked by Wall St. Rank hold EWTX as of Q4 2023.

  • Cornercap Investment Counsel reported no remaining Edgewise Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 26,023 Edgewise Therapeutics shares in Q4 2023, an estimated $149K.
  • Cornercap Investment Counsel first reported a position in Edgewise Therapeutics in Q1 2023 and held it in 3 quarters.
  • Cornercap Investment Counsel's Edgewise Therapeutics position peaked at $213K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2023.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.